Trent Melanie Montague
Known title: DirectorCIK: 0001343137
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Hyliion's KARNO Power Module Named to TIME's Best Inventions 2026. Hyliion announced that its KARNO Power Module has been selected for TIME’s Best Inventions of 2026. The recognition highlights the company's progress in hydrogen‑fuel technology and may increase awareness of its products. The stock is currently trading near a long‑term support level, with an RSI indicating modest momentum.
Transaction History
| FANG | ▲ Buy | Grant | 982 | $0 | 5/20/2026 | View on chart |
| HYLN | ▲ Buy | Grant | 60,976 | $125K | 2/11/2026 | View on chart |
| FANG | ▲ Buy | Grant | 1,417 | $0 | 5/21/2025 | View on chart |
| HYLN | ▲ Buy | Grant | 59,809 | $0 | 2/18/2025 | View on chart |
| FANG | ▲ Buy | Grant | 1,035 | $0 | 6/6/2024 | View on chart |
| HYLN | ▲ Buy | Grant | 78,125 | $0 | 2/13/2024 | View on chart |
| FANG | ▲ Buy | Grant | 1,527 | $0 | 6/8/2023 | View on chart |
| HYLN | ▲ Buy | Grant | 19,864 | $0 | 3/17/2023 | View on chart |
| FANG | ▲ Buy | Grant | 1,274 | $0 | 6/9/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Diamondback Energy Analyst Ratings and Price Targets Updated
Recent analyst actions highlight strong interest in Diamondback Energy, with Scotiabank initiating coverage with an Outperform rating and a $250 price target. RBC Capital reiterated its Outperform stance at $240, while Morgan Stanley maintained Equal-Weight and raised its target to $222. These updates come ahead of the company's upcoming earnings report, reflecting continued sector attention.
Diamondback Energy Analyst Ratings and Price Targets Updated. Recent analyst actions highlight strong interest in Diamondback Energy, with Scotiabank initiating coverage with an Outperform rating and a $250 price target. RBC Capital reiterated its Outperform stance at $240, while Morgan Stanley maintained Equal-Weight and raised its target to $222. These updates come ahead of the company's upcoming earnings report, reflecting continued sector attention.